Pan-KRAS inhibitor (Insilico Medicine)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NamePan-KRAS inhibitor (Insilico Medicine)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionV-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog inhibitors
TargetsGTPase KRas
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsilico Medicine Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A